Items where Author is "Anbarasu, Kannan"
![]() | Up a level |
Mubthasima, P. P. and Sridevi Annapurna, Singh and Anbarasu, Kannan (2024) Sesamol-mediated targeting of EPHA2 sensitises cervical cancer for cisplatin treatment by regulating mitochondrial dynamics, autophagy and mitophagy. Molecular Biology Reports, 51. p. 949.
Mubthasima, P. P. and Anbarasu, Kannan (2024) Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β‑estradiol on cancer progression. Medical Oncology, 41 (255).
Kaumudi, Pande and Bettadaiah, B. K. and Anbarasu, Kannan (2024) A biocompatible nanoformulation of curcumin analogue and curd exosomes targeting EphA2 signalling cascade in head and neck cancer. Pande et al. Cancer Nanotechnology, 15 (50). pp. 1-23.
Trideva Sastri, K. and Vishal Gupta, N. and Anbarasu, Kannan and Suman, Dutta and Riyaz Ali Osmani, M. and Balamuralidhara, V. and Ramkishan, A. and Shanmuganathan, S. (2024) The next frontier in multiple sclerosis therapies: Current advances and evolving targets. European Journal of Pharmacology, 985. pp. 1-35.